Al-Munther Sultan

Managing Director
Focuses on healthcare and life sciences M&A 
15+ years of experience advising founder-owners, private equity and corporates 
Expert in business exits, fund raising/partial company exits and buy-side support
London
@alvarezmarsal
LinkedIn
Copied!
Al-Munther Sultan is a Managing Director of Healthcare and Life Sciences with Alvarez & Marsal in London.

Mr. Sultan has spent over 15 years advising founder-owners, private equity and corporates on a range of M&A services, including business exits, fund raising/partial company exits and acquisition support. He has led notable transactions, most recently the sale of private equity backed Vanguard Healthcare Solutions to iCON Infrastructure and the sale of Aesthetic Technology to Omni Partners. 

Prior to joining A&M, Mr. Sultan was Director, Healthcare & Life sciences M&A with KPMG, where he held a senior position in its M&A practice for the past six years. Prior to this he worked in other M&A advisory firms and in leveraged finance for an international bank. 

Mr. Sultan earned a bachelor’s degree in accounting and finance from Liverpool University.

Insights By This Professional

In the UK, rapid digital health innovation and the government’s first-ever strategic response has meant that the men’s health sector is currently undergoing a shift that is breaking long-standing stigma and moving the market from low engagement to systemic change.
The global orthopaedics market is valued at $62 billion and is projected to reach $81 billion by 2030 at a 4.3% CAGR. In contrast, the UK market is expanding more rapidly, with a 6.5% CAGR, rising from $1.9 billion to $2.6 billion by 2030.
Neurodiversity encompasses a spectrum of neurological conditions. With an estimated 1 in 7 people in the UK considered neurodivergent, demand for services is rising.
The fertility treatment industry is a vital and rapidly-expanding sector in global healthcare, fueled by demographic shifts, tech innovations, evolving social norms, and tighter regulations. Once a niche service primarily for couples with infertility, assisted reproductive technologies (ART) now drive family planning, gender-inclusive care, and solutions to demographic challenges.
Latest insights The latest insights from Al-Munther Sultan's team
Thought Leadership
In the UK, rapid digital health innovation and the government’s first-ever strategic response has meant that the men’s health sector is currently undergoing a shift that is breaking long-standing stigma and moving the market from low engagement to systemic change.